The Global Pharmaceuticals Excipients Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.
Pharmaceutical Excipients Excipients are crucial to drug delivery within the body. Generally, an excipient has no medicinal properties. Its standard purpose is to streamline the manufacture of the drug product and ultimately facilitate physiological absorption of the drug. Excipients might aid in lubricity, flowability, disintegration, taste and may confer some form of antimicrobial function. Selecting the appropriate excipient to support the design of your pharmaceutical formulation is an important step in the drug manufacturing process.
Pharmaceutical excipients are inert substances, other than the pharmacologically active drug, which are included in the manufacturing process or are present in the pharmaceutical product dosage form. Excipients are widely used in drug formulation to provide long-term stability, add bulkiness to solid formulations and facilitate drug absorption. They also enhance the overall safety or functionality of the product during storage or use.
Scope of the Report:
The worldwide market for Pharmaceuticals Excipients is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019.
This report focuses on the Pharmaceuticals Excipients in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- DowDuPont (FMC)
- ER-KANG
- JRS Pharma
- BASF
- Lubrizol
- Ashland
- Roquette
- Shin-Etsu
- Evonik
- Associated British Foods
- Anhui Sunhere Pharmaceutical
- CHASE SUN
- Shenzhou Yiqiao
- EHUA
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Binder
- Glidents
- Diluents
- Disintegrants
- Other
Market Segment by Applications, can be divided into
- Oral Formulations
- Topical Formulations
- Parenteral Formulations
- Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pharmaceuticals Excipients product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pharmaceuticals Excipients, with price, sales, revenue and global market share of Pharmaceuticals Excipients in 2017 and 2018.
Chapter 3, the Pharmaceuticals Excipients competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pharmaceuticals Excipients breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Pharmaceuticals Excipients market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Pharmaceuticals Excipients sales channel, distributors, customers, research findings and conclusion, appendix and data source.